They discovered several downstream target pathways that are commonly deregulated in fusion-positive sarcomas and observed an overlap between EWSR1-WT1 and EWSR1-FLI1 (the fusion gene driving Ewing sarcoma) gene signatures. The gene discussed is EWSR1; the disease is Ewing sarcoma.